AAV manufacturing process development using fast USP and DSP HPLC analytics
Feb
17
2022
On demand

AAV manufacturing process development using fast USP and DSP HPLC analytics

Thursday 08:00 PST / 11:00 EST / 16:00 GMT / 17:00 CET
Sponsor
AAV manufacturing process development using fast USP and DSP HPLC analytics

One of the key challenges in manufacturing viral vectors is to increase the ratio between empty and full capsids.

When the expression in the cell line results in less than 10% full capsid it is quite impossible to reach better than 90% full in the final product. It is therefore mandatory to optimise the USP to result in better empty/full ratio.

This can be efficiently realised by using at-line HPLC to allow for analysis of the full and empty capsids ratio directly in the harvest.

The residual empty capsids can be removed by polishing step using different anion exchange columns.

  • AAV is the leading vector in the field of gene therapy and it is therefore crucial to develop a robust and high efficiency platform for its manufacturing. 
  • In-process analytics of vector capsid production is a critical optimization target in development of AAV-based gene therapy products. 
  • In this presentation we introduce a fast at-line HPLC based system that enables analysis of the full and empty capsids ratio directly in the harvest. 
  • Insights about purification will also be discussed.
Aleš Štrancar
Aleš Štrancar
Sartorius BIA Separations

Ales Štrancar is executive managing director of BIA Separations, now a Sartorius company, since funded in 1998. He is one of the main inventors of the CIM Convective Interaction Media® monolithic columns technology and co-inventor of many analytical methods and purification processes including pDNA, mRNA, AAV, Adeno and other viruses. Aleš is author or co-author of more than 90 scientific papers dealing with separation and purification technologies. He is a co-author of several granted USA patents and their foreign equivalents in the field of biomolecule separations and purification.

SPEAKERS

Aleš Štrancar
Aleš Štrancar
Sartorius BIA Separations

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual
27 June
in 69
Days
Register
Pure and simple: understanding LNP analytics for better mRNA-based drugs

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe
29 May
in 40
Days
Register
Empowering patient care: in-process and quality control solutions for cellular therapies

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz
23 May
in 34
Days
Register
T cells from beginning to end: optimizing leukopak and drug product cryopreservation

T cells from beginning to end: optimizing leukopak and drug product cryopreservation

Meredith Safford, ShaNelle Yelity
22 May
in 33
Days
Register
Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time

Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time

Emily Jackson-Holmes
21 May
in 32
Days
Register